MILabs U-SPECT/CT imaging in immuno-oncology

MILabs U-SPECT/CT imaging in immuno-oncology

by Dr. Sandra Heskamp, Department of Medical Imaging, Radboudumc, Nijmegen, The Netherlands

This webinar describes the key applications of nuclear imaging in immuno-oncology. Currently, numerous immuno-oncological drugs are being developed to treat cancer patients. However, many questions remain unanswered, such as how, when, and for whom this treatment is most effective. Dr. Sandra Heskamp will show a few examples of imaging approaches developed in her group to tackle these questions.

Took place: January, 2021

CT,SPECT

You may also like

Bart Cornelissen imaging DNA damage webinar thumbnail
Imaging DNA damage
CT,PET,SPECT
Each DNA damage repair pathway leads to the recruitment, upregulation, or activation of specific proteins within the nucleus, which, in some cases, can represent attractive targets for molecular imaging.
Fabian Kiessling webinar thumbnail
Quantitative hybrid fluorescence and CT to assess drug biodistribution in cancer research
CT,Optical
For a detailed biodistribution analysis, PET and SPECT are usually preferred as they are more accurate and quantitative, so the question is, can optical imaging become a complementary tool for pre-clinical biodistribution analysis.
webinar thumnail Marko Rosenholm
Dynamic SPECT/CT imaging of glymphatic drug delivery and clearance in small animals
CT,SPECT
Marko Rosenholm presents some of the findings and results regarding dynamic SPECT/CT imaging of a glymphatic system they have acquired with the MILabs VECTor/CT system.

Global Sales, Service & Support

Duwboot 7a
3991 CD  Houten
The Netherlands

Phone: +31 85 088 5753
Fax: +31 88 756 0094
E-mail: [email protected]
REQUEST MORE INFORMATION

Distributors

MILabs products are used in more than 65 countries and are supported by a global network of distributors and factory trained support engineers.

Please contact MILabs directly for more information about your local MILabs business partner.

Scroll to Top